Since CDI is associated with worse clinical outcomes in patients, several indicators, including laboratory results like WBC count and serum albumin level, patient symptoms, and hemodynamic changes have been proposed to discriminate disease severity (Surawicz et al., 2013; McDonald et al., 2018; Johnson et al., 2021). Here, ALB is linked to clostridium difficile infection.